Objective-To test whether very early resumption of ambulation after femoral cardiac catheterisation is feasible and safe in patients with stable symptoms. Design-Prospective study in a selected group of men and women undergoing elective cardiac catheterisation, with next day physical inspection. Setting-Inpatient study.
Abstract
Objective-To test whether very early resumption of ambulation after femoral cardiac catheterisation is feasible and safe in patients with stable symptoms. Design-Prospective study in a selected group of men and women undergoing elective cardiac catheterisation, with next day physical inspection. Setting-Inpatient study. Subjects-Two hundred consecutive ambulant patients submitted to diagnostic cardiac catheterisation through the femoral arterial route using 5F catheters: a femoral right heart study was done at the same time in 40 patients (20%). Results-No patient had major complications during the study. Early ambulation was not allowed in two patients (1%) because of haematoma formation immediately after sheath removal, and in seven (3%) because of poor haemostasis or haematoma on inspection at 3 h. Early ambulation was interrupted in two patients (1%) because of transient arterial hypotension on standing in one, and the patient's preference in the other. Of 189 patients who resumed full ambulation at 3 h, one (0.5%) had a groin haematoma on discharge the next morning. Overall, haematoma 12 h after cardiac catheterisation was present in seven of the 200 patients initially included in the study (3.5% transplantation. Early discharge after cardiac catheterisation can add to patients' satisfaction, improve the utilisation of both inpatient and outpatient facilities, and reduce costs. Early mobilisation after femoral coronary arteriography has been described. [1] [2] [3] The potential for significant arterial bleeding or cardiac complications, however, remains of concern for many cardiologists, and prolonged bed rest is generally recommended after transfemoral cardiac catheterisation. This has also been current practice in our centre since 1992, and outpatients have not been allowed to resume ambulation before six hours following cardiac catheterisation. 4 Our aim in this study was to evaluate, in a prospective trial, the safety of very early mobilisation after elective cardiac catheterisation with femoral arterial 5F (French) catheters. Patients remained at rest in bed for 3 h until they were seen by one of the nurses of the catheterisation laboratory. Before asking the patient to get up and walk the vital signs were observed, the bandage was removed, the puncture site was inspected, and an electrocardiogram was recorded. The study protocol was terminated (late dropout) if local haemostasis was not satisfactory, or if haematoma, uncontrolled arterial hypertension (systolic blood pressure > 180 mm Hg), cardiac symptoms, or ischaemic changes on the electrocardiogram were present at that time.
Methods
Early ambulation was supervised by the nurse during 10-15 min; it was interrupted (interrupted ambulation) and bed rest was resumed if there was severe vasovagal hypotension on standing, or if the patient preferred this for whatever reason. After early ambulation under supervision the patient's activities in the ward were unlimited (unrestricted ambulation). All patients were seen by one of the cardiologists of the cardiac catheterisation laboratory the next day, 12 h or later after resumption of ambulation. Physical inspection of the patient was performed, with palpation and auscultation of the puncture site and femoral pulses, and an electrocardiogram was recorded. Late follow up data for all patients with early mobilisation were obtained after completion of the study, to detect possible vascular complications at the access site. The referring physician, or primary physician of each patient, was required to provide detailed information about the status of the femoral access site on inspection. Data were collected during a second telephone interview some weeks later, to allow for either retrieval of medical records or a new accurate examination of the patient. Whenever the referring or primary physician had not seen the patient one month or later after cardiac catheterisation, or was unable to provide specific information as required, the patient was contacted by a cardiologist by telephone; questions were asked about pain, swelling, or abnormalities observed at the vascular access site, and numbness or pain in the leg during ambulation.
The research protocol was approved by the ethics committee of our hospital and the informed consent of the subjects was obtained in all cases.
Results
The clinical characteristics, indications for cardiac catheterisation, and diagnoses are summarised in table 2. The study patients represented about 25% of all patients who underwent diagnostic cardiac catheterisation in the study period in our centre. The admission criteria (table 1) were not met by 597 patients: 125 had elective cardiac catheterisation performed on a day hospital basis (8 h hospital stay), and 238 were brought by ambulance to our centre from nearby hospitals immediately before the procedure (elective) and taken back 1-3 h after it; in neither case would direct inspection of the femoral wound have been possible the next morning. Acute unstable angina or recent myocardial infarction was the reason for performing urgent coronary angiography in 205 patients during their admission to this or other hospitals; these patients had not been mobilised before catheterisation, and many were receiving intravenous heparin. Finally, early mobilisation was not considered in 29 patients with severe valvar disease, uncompensated heart failure, or ongoing oral anticoagulation.
Procedural variables are listed in table 3. In no case did a larger catheter have to be substituted for the standard 5-2F catheters because of poor manoeuvrability, whiplash/recoil, or unsatisfactory coronary opacification, and images of acceptable diagnostic quality were obtained in all patients.
Ambulation after elective cardiac catheterisation (3 5% ) of patients initially included in the study. A small, non-tender subcutaneous extravasation of blood (bruise) without swelling was observed in 10 patients (5%).
Follow up data at 5 (SD 3) months (range 1 to 8 months) after cardiac catheterisation were obtained for all 191 patients with attempted early mobilisation. In 180 cases the physician had seen the study patient at least once one month or later after cardiac catheterisation, and could provide information from inspection of the vascular access site; in no case were vascular complications observed. Haematoma had disappeared without sequelae about two weeks after cardiac catheterisation in the only patient showing this complication at discharge. A direct telephone interview was attempted with 1 1 patients: one had died following coronary artery bypass surgery 10 days after cardiac catheterisation; the remaining 10 had no signs or symptoms of vascular complications-in one case following a coronary angioplasty procedure performed about 7 d after diagnostic cardiac catheterisation through the same femoral artery.
Discussion
Although the performance of 5F catheters for cardiac catheterisation appeared unsatisfactory in many early trials,267 these catheters are nowadays used for cardiac catheterisation in many centres by both the brachial89 and the femoral'0 route, because of technical improvements in catheter quality, x ray imaging equipment, and operator experience. Large lumen 5-2F catheters have been routinely used for percutaneous femoral and brachial arterial cardiac catheterisation in our laboratory in over 3000 patients since 1992, with only exceptional need (0 4% of patients) for 7F catheters due to peripheral vessel tortuosity, or poor coronary opacification in individual patients with severe aortic regurgitation. The percutaneous brachial route is not used electively in our centre since it is less operator friendly in our angiographic suite, and greater radiation exposure for both the patient and the operator is reported with this approach.89 In all patients in this study, images of diagnostic quality could be obtained with 5-2F catheters, at the price of one additional catheter exchange in 8% of cases. Our mean fluoroscopy time (5 5 min), however, compares favourably with other studies of both femoral (mean 6&6 min),' and brachial (mean 8&7 min)7 cardiac catheterisation using 5F catheters, despite a right heart study and retrograde catheterisation of a stenotic aortic valve being performed in 20% and 1 1% of our patients, respectively.
Elective outpatient 7F or 8F femoral cardiac catheterisation with ambulation at six hours has been reported to be complicated by acute myocardial infarction in 1 6% of patients, and haematoma or other vascular problems in 14% of patients.' More recent studies support the safety of five hour,'0 four hour," and three hour2 immobilisation after femoral cardiac catheterisation with 5F or 6F catheters, with no major complications after the procedure, and a 1%, 1-5%, and 10% incidence, respectively, of haematoma. In one of these reports, however, there were large deviations (range one to nine hours) from the target ambulation time.2 Right heart catheterisation as a part of the procedure was not described in these studies, protamine was routinely used for heparin reversal before clamp compression, and no direct inspection was performed the next day. Only inpatients were included in our study, no protamine was used, and a careful physical inspection was performed before discharge in all cases.
Our minor acute vascular complication rate (3 5% overall) compares favourably with the 10% reported by Kern et Femoral arteriovenous fistula or pseudoaneurysm formation may be of concern following early mobilisation after femoral catheterisation. These late (> two weeks) vascular sequelae are reported to occur in < 0 5% of cases with the use of larger catheters.12 These complications almost invariably cause symptoms, and come to the attention of the general practitioner or referring physician. Follow up information at one month or later after cardiac catheterisation, from either inspection by a physician or a direct telephone interview with the patient, had the potential to detect severe vascular problems occurring late after cardiac catheterisation; this was not the case in any of the study patients.
In conclusion, our data confirm that supervised resumption of ambulation three hours after an uncomplicated cardiac study with 5F arterial catheters is safe and can be applied to most ambulant patients undergoing elective cardiac catheterisation in stable conditions. Minor acute vascular complications should not be of concern in this setting, since their incidence is very low and is not appreciably increased by early mobilisation itself. The concomitant performance of a femoral right heart study does not appear to increase the risk of early vascular complications in these patients.
Late sequelae at the vascular access site are infrequent, and were not likely to be encountered in our patients because of the limited sample size of the study; although conclusions cannot be drawn as to the incidence of femoral arteriovenous fistula or pseudoaneurysm after early mobilisation following femoral catheterisation with 5F catheters, these complications were not observed in any of our patients.
It may be of interest that, on the basis of this study, supervised resumption of ambulation in now being implemented whenever appropriate by the nurses on our ward. This appears to improve the comfort of patients, especially the elderly, and to reduce the need for bed assistance by the personnel. The shorter rest in bed has not increased the number of outpatient cardiac catheterisation procedures in our centre, where a busy day hospital is run by the personnel of the cardiac laboratory. It allows us, however, to discharge in the early afternoon most day hospital patients admitted early in the morning. Using the same bed for two consecutive patients the same day would thus become possible, if required.
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